medigraphic.com
SPANISH

Archivos de Investigación Materno Infantil

ISSN 2007-3194 (Print)
Órgano de difusión oficial del Instituto Materno Infantil del Estado de México
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2010, Number 3

<< Back

Arch Inv Mat Inf 2010; 2 (3)

Migraña infantil: prevalencia y características clínicas

Bastida ME, Contreras BJI
Full text How to cite this article

Language: Spanish
References: 14
Page: 141-144
PDF size: 143.79 Kb.


Key words:

Migraine, childhood migraine, headache.

ABSTRACT

Migraine is a paroxysmal headache intermittent pattern. In Mexico, the annual prevalence of migraine is 12.1% in women and 3.9% in men. Objective: To determine the prevalence and clinical features of childhood migraine population. Material and methods: We reviewed the records of patients diagnosed with migraine of neurology at the Hospital Materno- Infantil ISSEMYM, 2008. Results: The prevalence of migraine was 9.2%. 100% of the patients had accompanying symptoms, on average 3.2 symptoms. Nausea and photophobia were most common in 70.2% of cases, followed by phonophobia in 67.7% of cases. Conclusions: The prevalence was 9.2% at a woman/man 1.1:1, similar to figures reported in other series.


REFERENCES

  1. Gracia-Naya M, Alarcia-Alejos R, Modrego-Pardo PJ. Importancia de la migraña crónica en la consulta general de neurología. Rev Neurol 2008; 46 (10): 577-581.

  2. Lewis DW. Pediatric migraine. Neurol Clin 2009; 27 (2): 481- 501.

  3. Hernández-Latorre MA, Macaya-Ruiz A, Roig-Quilis M. Características clínicas de la migraña en la edad pediátrica. Rev Neurol 2001; 33 (8): 708-715.

  4. Volcy-Gómez M. Impacto social, económico y en el sistema de salud de la migraña y otras cefaleas primarias. Rev Neurol 2006; 43 (4): 228-235.

  5. Comité de Clasificación de las Cefaleas de la International Headache Society. Cephalalgia 1988; 8(suppl. 7): 9-96.

  6. Ferrari MD. Migraine genetics: a fascinating journey towards improved migraine therapy. Headache 2008; 48 (7): 1044-55.

  7. Chugani DC, Niimura K, Chaturvedi S et al. Increased brain serotonin synthesis in migraine. Neurology 1999; 53: 1473.

  8. Evans RW. Migraine: a question and answer review. Med Clin North Am 2009; 93 (2): 245-262.

  9. Arroyo HA. Migraña y otras cefaleas primarias en la infancia y la adolescencia. Medicina (Buenos Aires) 2007; 67 (6/1): 623- 630.

  10. Durá-Travé T, Yoldi-Petri ME. Validez de los criterios diagnósticos de migraña en la edad pediátrica. Rev Neurol 2004; 38 (12): 1123-1127.

  11. Kernick D, Campbell J. Measuring the impact of headache in children: a critical review of the literature. Cephalalgia 2008; 29: 3-16.

  12. Goadsby PJ. Recent advances in the diagnosis and management of migraine. BMJ 2006; 332: 25-29.

  13. Ryan VS. Drugs for preventing migraine headaches in children (review). The Cochrane Library 2008, issue 4.

  14. Edelstein BR. Chronic migraine and medication overuse headache:clarifying the current international headache society classification criteria. Cephalalgia 2008; 29: 445-452.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Arch Inv Mat Inf. 2010;2